#wvcusa A novel Japanese Encephalitis Vaccine by Intercell

Jeffrey Hackman, President and CEO, Intercell USA presented yesterday at the World Vaccine Congress the latest developments of this JEV Vaccine with a favorable safety profile and global distribution strategy. Japanese Encephalitis Vaccine:  Intercell currently has a licensed product against Japanese encephalitis.  They have developed it through a partnership model.  The company has an innovative R&D group and manufacturing facilities.  …